Home > Drug Search >
  • Targets: Endotoxin
  •   > 
Drug Filter
Category:
chemistry (26) biology (3)
Status:
Withdrawn (1) NDA Filing (1) Phase Ⅲ (3) Phase Ⅱ (10) Phase Ⅰ (14)
Clinical Stage:
Pending (3) Active (11) Discontinued (14)
Bio-Type:
Recombinant cytokines (1) Other recombinant protein (1) Whole antibody (1)
Company:
Gilead (1) GlaxoSmithKline (2) Hansoh Pharma (1) ILDONG PHARMACEUTICAL (1) Johnson & Johnson (1) Kyowa Hakko Kirin (1) Millennium Pharmaceutical (1) Mitsubishi Tanabe Pharma (1) National Cancer Institute (1) Novartis (1) Oscient Pharmaceutical (1) FinVector Vision Therapies (1) Pfizer (3) Procter & Gamble (1) PTC Therapeutics (1) Roche (1) Sanofi (1) Takeda (2) Vernalis (1) Sepsicure (1) Arno Therapeutics (1) Spinifex Pharmaceutical (1) Xoma (2) Frontier Biotechnologies (Nanjing) (1) Tianjin FusoGen Pharmaceuticals (1) La Jolla (1) Agensys (1) Alexion (1) Bayer (1) Biotech Pharmaceutical (1) ChemoCentryx (1)
Indication:
Acne (1) Alzheimer's disease (AD) (1) Chemotherapy-induced peripheral neuropathy (1) Community-acquired pneumonia (CAP) (2) Endometriosis (1) HIV infection (4) Hypertension (4) Impetigo (1) Lymphoma (2) Melanoma (1) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (2) Myeloid leukemia (1) Ovarian cancer (2) Pancreatic cancer (1) Postherpetic neuralgia (PHN) (1) Psoriasis (1) Rheumatoid arthritis (RA) (3) Small cell lung cancer (SCLC) (1) Solid tumours (3) Nosocomial Pneumonia (NP) (1) Bacterial Pneumonia (1) Diagnostic agents (1) Sepsis (1) Septic shock (2) Hypotension (1) Respiratory syncytial virus infection (1) Bacterial infection (4) Chemotherapy-induced myelosuppression (1) Ebola virus disease (EVD) (1) Inflammation (1) Cachexia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top